

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | drug catabolic process (GO:0042737) | 8.20671436 |
| 2 | glyoxylate metabolic process (GO:0046487) | 7.99335865 |
| 3 | exogenous drug catabolic process (GO:0042738) | 7.85980808 |
| 4 | epoxygenase P450 pathway (GO:0019373) | 7.01933045 |
| 5 | omega-hydroxylase P450 pathway (GO:0097267) | 6.89826748 |
| 6 | serine family amino acid catabolic process (GO:0009071) | 6.82267146 |
| 7 | oxidative demethylation (GO:0070989) | 6.21206430 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.98073603 |
| 9 | L-phenylalanine catabolic process (GO:0006559) | 5.98073603 |
| 10 | complement activation, alternative pathway (GO:0006957) | 5.86321848 |
| 11 | regulation of fibrinolysis (GO:0051917) | 5.84352545 |
| 12 | glycine metabolic process (GO:0006544) | 5.63827271 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.52574812 |
| 14 | negative regulation of fibrinolysis (GO:0051918) | 5.51812542 |
| 15 | phenylpropanoid metabolic process (GO:0009698) | 5.43125023 |
| 16 | regulation of protein activation cascade (GO:2000257) | 5.29814697 |
| 17 | ethanol oxidation (GO:0006069) | 5.12578030 |
| 18 | aromatic amino acid family catabolic process (GO:0009074) | 5.06907858 |
| 19 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.99751883 |
| 20 | drug metabolic process (GO:0017144) | 4.93948109 |
| 21 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.87339327 |
| 22 | L-phenylalanine metabolic process (GO:0006558) | 4.87339327 |
| 23 | regulation of complement activation (GO:0030449) | 4.78197860 |
| 24 | cellular glucuronidation (GO:0052695) | 4.71428278 |
| 25 | protein carboxylation (GO:0018214) | 4.64822495 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.64822495 |
| 27 | serine family amino acid metabolic process (GO:0009069) | 4.64621755 |
| 28 | urea metabolic process (GO:0019627) | 4.56504519 |
| 29 | glucuronate metabolic process (GO:0019585) | 4.54282297 |
| 30 | uronic acid metabolic process (GO:0006063) | 4.54282297 |
| 31 | S-adenosylmethionine metabolic process (GO:0046500) | 4.53274172 |
| 32 | bile acid metabolic process (GO:0008206) | 4.52869999 |
| 33 | fibrinolysis (GO:0042730) | 4.36046870 |
| 34 | bile acid and bile salt transport (GO:0015721) | 4.34448671 |
| 35 | alkaloid metabolic process (GO:0009820) | 4.31446868 |
| 36 | indole-containing compound catabolic process (GO:0042436) | 4.25871640 |
| 37 | indolalkylamine catabolic process (GO:0046218) | 4.25871640 |
| 38 | tryptophan catabolic process (GO:0006569) | 4.25871640 |
| 39 | heme transport (GO:0015886) | 4.24212343 |
| 40 | blood coagulation, intrinsic pathway (GO:0007597) | 4.20334401 |
| 41 | cellular ketone body metabolic process (GO:0046950) | 4.15143408 |
| 42 | nucleobase catabolic process (GO:0046113) | 4.12664277 |
| 43 | nitrogen cycle metabolic process (GO:0071941) | 4.03388531 |
| 44 | regulation of triglyceride catabolic process (GO:0010896) | 3.92552970 |
| 45 | negative regulation of sterol transport (GO:0032372) | 3.91917016 |
| 46 | negative regulation of cholesterol transport (GO:0032375) | 3.91917016 |
| 47 | arginine metabolic process (GO:0006525) | 3.86670662 |
| 48 | ethanol metabolic process (GO:0006067) | 3.85951685 |
| 49 | alpha-amino acid catabolic process (GO:1901606) | 3.84036675 |
| 50 | triglyceride homeostasis (GO:0070328) | 3.74686474 |
| 51 | acylglycerol homeostasis (GO:0055090) | 3.74686474 |
| 52 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.72714183 |
| 53 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.71367652 |
| 54 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.71367652 |
| 55 | aldehyde catabolic process (GO:0046185) | 3.70262979 |
| 56 | amino-acid betaine metabolic process (GO:0006577) | 3.70163609 |
| 57 | urea cycle (GO:0000050) | 3.68880509 |
| 58 | serine family amino acid biosynthetic process (GO:0009070) | 3.64521495 |
| 59 | ketone body metabolic process (GO:1902224) | 3.62880369 |
| 60 | imidazole-containing compound metabolic process (GO:0052803) | 3.57266342 |
| 61 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.55179606 |
| 62 | tryptophan metabolic process (GO:0006568) | 3.52580982 |
| 63 | protein activation cascade (GO:0072376) | 3.50176000 |
| 64 | steroid catabolic process (GO:0006706) | 3.46617467 |
| 65 | regulation of humoral immune response (GO:0002920) | 3.44781117 |
| 66 | cellular biogenic amine catabolic process (GO:0042402) | 3.36234621 |
| 67 | amine catabolic process (GO:0009310) | 3.36234621 |
| 68 | hormone catabolic process (GO:0042447) | 3.34276454 |
| 69 | aromatic amino acid family metabolic process (GO:0009072) | 3.31144984 |
| 70 | complement activation (GO:0006956) | 3.30638341 |
| 71 | regulation of glucokinase activity (GO:0033131) | 3.27370863 |
| 72 | regulation of hexokinase activity (GO:1903299) | 3.27370863 |
| 73 | opsonization (GO:0008228) | 3.25077802 |
| 74 | cellular amino acid catabolic process (GO:0009063) | 3.24224612 |
| 75 | regulation of plasminogen activation (GO:0010755) | 3.21085113 |
| 76 | negative regulation of blood coagulation (GO:0030195) | 3.12981371 |
| 77 | negative regulation of hemostasis (GO:1900047) | 3.12981371 |
| 78 | kynurenine metabolic process (GO:0070189) | 3.12444041 |
| 79 | cytolysis (GO:0019835) | 3.11496124 |
| 80 | complement activation, classical pathway (GO:0006958) | 3.08148263 |
| 81 | sodium-independent organic anion transport (GO:0043252) | 3.07457286 |
| 82 | L-methionine salvage (GO:0071267) | 3.05366701 |
| 83 | L-methionine biosynthetic process (GO:0071265) | 3.05366701 |
| 84 | amino acid salvage (GO:0043102) | 3.05366701 |
| 85 | protein-lipid complex remodeling (GO:0034368) | 3.04259055 |
| 86 | macromolecular complex remodeling (GO:0034367) | 3.04259055 |
| 87 | plasma lipoprotein particle remodeling (GO:0034369) | 3.04259055 |
| 88 | tyrosine metabolic process (GO:0006570) | 3.03995977 |
| 89 | iron coordination entity transport (GO:1901678) | 3.03795100 |
| 90 | peptidyl-glutamic acid modification (GO:0018200) | 3.02461341 |
| 91 | indolalkylamine metabolic process (GO:0006586) | 3.02239003 |
| 92 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.01998590 |
| 93 | cysteine metabolic process (GO:0006534) | 3.01210931 |
| 94 | glutamate metabolic process (GO:0006536) | 2.99655165 |
| 95 | arginine catabolic process (GO:0006527) | 2.99469691 |
| 96 | dopamine transport (GO:0015872) | 2.98476315 |
| 97 | negative regulation of wound healing (GO:0061045) | 2.94860943 |
| 98 | negative regulation of protein activation cascade (GO:2000258) | 2.93614646 |
| 99 | coenzyme catabolic process (GO:0009109) | 2.93461425 |
| 100 | behavioral response to nicotine (GO:0035095) | 2.91539885 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.86720609 |
| 2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.67299951 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.63378877 |
| 4 | VDR_22108803_ChIP-Seq_LS180_Human | 3.34554665 |
| 5 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.14828726 |
| 6 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.05485647 |
| 7 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.80825677 |
| 8 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.52727315 |
| 9 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.42815372 |
| 10 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.41632425 |
| 11 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.36639978 |
| 12 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.32652116 |
| 13 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.25972589 |
| 14 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.20846749 |
| 15 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.12170206 |
| 16 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.09778903 |
| 17 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.06976306 |
| 18 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.06828725 |
| 19 | FUS_26573619_Chip-Seq_HEK293_Human | 2.02817906 |
| 20 | ER_23166858_ChIP-Seq_MCF-7_Human | 2.01320821 |
| 21 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.94211923 |
| 22 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.94118834 |
| 23 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.92105435 |
| 24 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.91973552 |
| 25 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.86215033 |
| 26 | P300_19829295_ChIP-Seq_ESCs_Human | 1.82730841 |
| 27 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.80819452 |
| 28 | EWS_26573619_Chip-Seq_HEK293_Human | 1.77046788 |
| 29 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.74180401 |
| 30 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.64579630 |
| 31 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.61454161 |
| 32 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.58784078 |
| 33 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.58082936 |
| 34 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.57763061 |
| 35 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.56119555 |
| 36 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.53578495 |
| 37 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.51787590 |
| 38 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.51766909 |
| 39 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.49343316 |
| 40 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.49100913 |
| 41 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.49100913 |
| 42 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.45976195 |
| 43 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.44918497 |
| 44 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.43673449 |
| 45 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.42523375 |
| 46 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.40775820 |
| 47 | STAT3_23295773_ChIP-Seq_U87_Human | 1.40603198 |
| 48 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.38271094 |
| 49 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.36265131 |
| 50 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.36047695 |
| 51 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.35596011 |
| 52 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.35596011 |
| 53 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.33449159 |
| 54 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.32499198 |
| 55 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32377698 |
| 56 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.30793746 |
| 57 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.29806426 |
| 58 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.29641700 |
| 59 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24186810 |
| 60 | TCF4_23295773_ChIP-Seq_U87_Human | 1.22687230 |
| 61 | NCOR_22424771_ChIP-Seq_293T_Human | 1.22189770 |
| 62 | AR_20517297_ChIP-Seq_VCAP_Human | 1.19443844 |
| 63 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.18061470 |
| 64 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.16526822 |
| 65 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.16009404 |
| 66 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.15795655 |
| 67 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.14666282 |
| 68 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.14464995 |
| 69 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.13776804 |
| 70 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.09630155 |
| 71 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.08766287 |
| 72 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.08573336 |
| 73 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.08562346 |
| 74 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.07972379 |
| 75 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.07953840 |
| 76 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.07858581 |
| 77 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.07298967 |
| 78 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.07229173 |
| 79 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.07229173 |
| 80 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06164340 |
| 81 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.06164340 |
| 82 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.06124210 |
| 83 | AR_25329375_ChIP-Seq_VCAP_Human | 1.06051852 |
| 84 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.05471316 |
| 85 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.04320891 |
| 86 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.04009988 |
| 87 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.03963165 |
| 88 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.03229873 |
| 89 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.03174245 |
| 90 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.02360572 |
| 91 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.01093954 |
| 92 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.00073760 |
| 93 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.97120626 |
| 94 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.95377353 |
| 95 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.95069972 |
| 96 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.94010663 |
| 97 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.93355158 |
| 98 | CBP_21632823_ChIP-Seq_H3396_Human | 0.93182987 |
| 99 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.92398427 |
| 100 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.92012033 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.81790650 |
| 2 | MP0005360_urolithiasis | 4.64180599 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.35611224 |
| 4 | MP0002876_abnormal_thyroid_physiology | 4.14605269 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.05624979 |
| 6 | MP0002138_abnormal_hepatobiliary_system | 3.87808212 |
| 7 | MP0005365_abnormal_bile_salt | 3.69852070 |
| 8 | MP0003195_calcinosis | 3.67106634 |
| 9 | MP0003252_abnormal_bile_duct | 3.41485127 |
| 10 | MP0003880_abnormal_central_pattern | 3.11380553 |
| 11 | MP0009697_abnormal_copulation | 2.90357150 |
| 12 | MP0006276_abnormal_autonomic_nervous | 2.14769325 |
| 13 | MP0003787_abnormal_imprinting | 2.11710354 |
| 14 | MP0003868_abnormal_feces_composition | 2.08430169 |
| 15 | MP0001666_abnormal_nutrient_absorption | 1.86535538 |
| 16 | MP0004133_heterotaxia | 1.85093910 |
| 17 | MP0002653_abnormal_ependyma_morphology | 1.82188768 |
| 18 | MP0006072_abnormal_retinal_apoptosis | 1.80844309 |
| 19 | MP0001984_abnormal_olfaction | 1.75001786 |
| 20 | MP0001764_abnormal_homeostasis | 1.72357418 |
| 21 | MP0000372_irregular_coat_pigmentation | 1.71079030 |
| 22 | MP0005332_abnormal_amino_acid | 1.64415054 |
| 23 | MP0003806_abnormal_nucleotide_metabolis | 1.63624188 |
| 24 | MP0005551_abnormal_eye_electrophysiolog | 1.61352718 |
| 25 | MP0008877_abnormal_DNA_methylation | 1.61211068 |
| 26 | MP0010329_abnormal_lipoprotein_level | 1.51446840 |
| 27 | MP0008995_early_reproductive_senescence | 1.41756896 |
| 28 | MP0004142_abnormal_muscle_tone | 1.41671826 |
| 29 | MP0008789_abnormal_olfactory_epithelium | 1.41559344 |
| 30 | MP0001986_abnormal_taste_sensitivity | 1.40685313 |
| 31 | MP0003123_paternal_imprinting | 1.34863804 |
| 32 | MP0006292_abnormal_olfactory_placode | 1.32574939 |
| 33 | MP0004019_abnormal_vitamin_homeostasis | 1.21713107 |
| 34 | MP0003121_genomic_imprinting | 1.21459281 |
| 35 | MP0009764_decreased_sensitivity_to | 1.17309243 |
| 36 | MP0004885_abnormal_endolymph | 1.13855937 |
| 37 | MP0008872_abnormal_physiological_respon | 1.13613544 |
| 38 | MP0000778_abnormal_nervous_system | 1.06279554 |
| 39 | MP0005423_abnormal_somatic_nervous | 1.04484608 |
| 40 | MP0002254_reproductive_system_inflammat | 1.02746446 |
| 41 | MP0003283_abnormal_digestive_organ | 1.02223810 |
| 42 | MP0002118_abnormal_lipid_homeostasis | 1.01013742 |
| 43 | MP0005394_taste/olfaction_phenotype | 0.96430192 |
| 44 | MP0005499_abnormal_olfactory_system | 0.96430192 |
| 45 | MP0002234_abnormal_pharynx_morphology | 0.95675133 |
| 46 | MP0003122_maternal_imprinting | 0.94904420 |
| 47 | MP0000609_abnormal_liver_physiology | 0.94856878 |
| 48 | MP0010386_abnormal_urinary_bladder | 0.94239964 |
| 49 | MP0002928_abnormal_bile_duct | 0.91432142 |
| 50 | MP0002638_abnormal_pupillary_reflex | 0.90607094 |
| 51 | MP0001293_anophthalmia | 0.89675305 |
| 52 | MP0002837_dystrophic_cardiac_calcinosis | 0.89164061 |
| 53 | MP0002282_abnormal_trachea_morphology | 0.89161880 |
| 54 | MP0005410_abnormal_fertilization | 0.86309583 |
| 55 | MP0005645_abnormal_hypothalamus_physiol | 0.85978865 |
| 56 | MP0005253_abnormal_eye_physiology | 0.84393293 |
| 57 | MP0002102_abnormal_ear_morphology | 0.83773267 |
| 58 | MP0005646_abnormal_pituitary_gland | 0.81300754 |
| 59 | MP0001485_abnormal_pinna_reflex | 0.80937799 |
| 60 | MP0009745_abnormal_behavioral_response | 0.80922197 |
| 61 | MP0004742_abnormal_vestibular_system | 0.78723210 |
| 62 | MP0003959_abnormal_lean_body | 0.78687209 |
| 63 | MP0008775_abnormal_heart_ventricle | 0.78274424 |
| 64 | MP0005408_hypopigmentation | 0.78148195 |
| 65 | MP0005395_other_phenotype | 0.77680911 |
| 66 | MP0002160_abnormal_reproductive_system | 0.77347625 |
| 67 | MP0001501_abnormal_sleep_pattern | 0.76836052 |
| 68 | MP0002272_abnormal_nervous_system | 0.76236501 |
| 69 | MP0003718_maternal_effect | 0.74426564 |
| 70 | MP0003656_abnormal_erythrocyte_physiolo | 0.74067460 |
| 71 | MP0005266_abnormal_metabolism | 0.74025626 |
| 72 | MP0005084_abnormal_gallbladder_morpholo | 0.73857463 |
| 73 | MP0005195_abnormal_posterior_eye | 0.73772541 |
| 74 | MP0010368_abnormal_lymphatic_system | 0.73761839 |
| 75 | MP0001486_abnormal_startle_reflex | 0.72445355 |
| 76 | MP0002132_abnormal_respiratory_system | 0.70720825 |
| 77 | MP0003890_abnormal_embryonic-extraembry | 0.69816009 |
| 78 | MP0001968_abnormal_touch/_nociception | 0.68972508 |
| 79 | MP0004859_abnormal_synaptic_plasticity | 0.68316021 |
| 80 | MP0001440_abnormal_grooming_behavior | 0.67623046 |
| 81 | MP0000631_abnormal_neuroendocrine_gland | 0.67395740 |
| 82 | MP0002067_abnormal_sensory_capabilities | 0.66765972 |
| 83 | MP0005389_reproductive_system_phenotype | 0.65933676 |
| 84 | MP0002822_catalepsy | 0.65718227 |
| 85 | MP0006036_abnormal_mitochondrial_physio | 0.64906372 |
| 86 | MP0009765_abnormal_xenobiotic_induced | 0.64445711 |
| 87 | MP0008961_abnormal_basal_metabolism | 0.63494509 |
| 88 | MP0009379_abnormal_foot_pigmentation | 0.63027240 |
| 89 | MP0003011_delayed_dark_adaptation | 0.60852294 |
| 90 | MP0002168_other_aberrant_phenotype | 0.59962010 |
| 91 | MP0005319_abnormal_enzyme/_coenzyme | 0.58323397 |
| 92 | MP0002938_white_spotting | 0.57978578 |
| 93 | MP0005386_behavior/neurological_phenoty | 0.57424557 |
| 94 | MP0004924_abnormal_behavior | 0.57424557 |
| 95 | MP0003638_abnormal_response/metabolism_ | 0.57284793 |
| 96 | MP0005376_homeostasis/metabolism_phenot | 0.56500832 |
| 97 | MP0002971_abnormal_brown_adipose | 0.55949425 |
| 98 | MP0009642_abnormal_blood_homeostasis | 0.55827975 |
| 99 | MP0001919_abnormal_reproductive_system | 0.55785869 |
| 100 | MP0000639_abnormal_adrenal_gland | 0.55308564 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged partial thromboplastin time (HP:0003645) | 6.21399261 |
| 2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.99115681 |
| 3 | Deep venous thrombosis (HP:0002625) | 5.87361061 |
| 4 | Complement deficiency (HP:0004431) | 5.29432317 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.19504034 |
| 6 | Hyperlipoproteinemia (HP:0010980) | 4.74286125 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 4.43176842 |
| 8 | Hyperglycinemia (HP:0002154) | 4.32379790 |
| 9 | Joint hemorrhage (HP:0005261) | 3.92900402 |
| 10 | Conjugated hyperbilirubinemia (HP:0002908) | 3.92759105 |
| 11 | Fair hair (HP:0002286) | 3.76614656 |
| 12 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.75407475 |
| 13 | Abnormality of complement system (HP:0005339) | 3.72470557 |
| 14 | Intrahepatic cholestasis (HP:0001406) | 3.64863433 |
| 15 | Chronic hepatic failure (HP:0100626) | 3.62186872 |
| 16 | Abnormality of methionine metabolism (HP:0010901) | 3.34653772 |
| 17 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.10500915 |
| 18 | Systemic lupus erythematosus (HP:0002725) | 2.97872795 |
| 19 | Abnormal biliary tract physiology (HP:0012439) | 2.97134580 |
| 20 | Bile duct proliferation (HP:0001408) | 2.97134580 |
| 21 | Abnormality of glycine metabolism (HP:0010895) | 2.90086608 |
| 22 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.90086608 |
| 23 | Generalized hypopigmentation of hair (HP:0011358) | 2.82199496 |
| 24 | Reduced antithrombin III activity (HP:0001976) | 2.80304479 |
| 25 | Abnormality of serum amino acid levels (HP:0003112) | 2.79103900 |
| 26 | Hyperglycinuria (HP:0003108) | 2.66602060 |
| 27 | Pancreatic fibrosis (HP:0100732) | 2.62737795 |
| 28 | Congenital stationary night blindness (HP:0007642) | 2.59355497 |
| 29 | Spontaneous abortion (HP:0005268) | 2.59189829 |
| 30 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.58524315 |
| 31 | Osteomalacia (HP:0002749) | 2.56850221 |
| 32 | Abnormality of midbrain morphology (HP:0002418) | 2.53941989 |
| 33 | Molar tooth sign on MRI (HP:0002419) | 2.53941989 |
| 34 | B lymphocytopenia (HP:0010976) | 2.49080074 |
| 35 | Thyroid-stimulating hormone excess (HP:0002925) | 2.48502291 |
| 36 | Methylmalonic acidemia (HP:0002912) | 2.47669721 |
| 37 | Thyroiditis (HP:0100646) | 2.46944778 |
| 38 | Septo-optic dysplasia (HP:0100842) | 2.44628267 |
| 39 | Xanthomatosis (HP:0000991) | 2.35308993 |
| 40 | Acute encephalopathy (HP:0006846) | 2.33983023 |
| 41 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.28984209 |
| 42 | True hermaphroditism (HP:0010459) | 2.28510837 |
| 43 | Nephronophthisis (HP:0000090) | 2.27981056 |
| 44 | Abnormality of the intrinsic pathway (HP:0010989) | 2.27815488 |
| 45 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.21969797 |
| 46 | Optic nerve hypoplasia (HP:0000609) | 2.21885552 |
| 47 | Abnormality of B cell number (HP:0010975) | 2.18166794 |
| 48 | Glomerulonephritis (HP:0000099) | 2.16131369 |
| 49 | Glycosuria (HP:0003076) | 2.15306082 |
| 50 | Abnormality of urine glucose concentration (HP:0011016) | 2.15306082 |
| 51 | Abolished electroretinogram (ERG) (HP:0000550) | 2.15155726 |
| 52 | Delayed CNS myelination (HP:0002188) | 2.14251162 |
| 53 | Metaphyseal dysplasia (HP:0100255) | 2.13536521 |
| 54 | Hypochromic microcytic anemia (HP:0004840) | 2.13430486 |
| 55 | Dyskinesia (HP:0100660) | 2.13147749 |
| 56 | Abnormality of the common coagulation pathway (HP:0010990) | 2.10136799 |
| 57 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.09958896 |
| 58 | Medial flaring of the eyebrow (HP:0010747) | 2.08358597 |
| 59 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.07356223 |
| 60 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.07015325 |
| 61 | Fat malabsorption (HP:0002630) | 2.06905295 |
| 62 | Hyperphosphaturia (HP:0003109) | 2.04907353 |
| 63 | Retinal dysplasia (HP:0007973) | 2.03066153 |
| 64 | Cerebral edema (HP:0002181) | 2.02662171 |
| 65 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.01840580 |
| 66 | Abnormality of alanine metabolism (HP:0010916) | 2.01840580 |
| 67 | Hyperalaninemia (HP:0003348) | 2.01840580 |
| 68 | Renal cortical cysts (HP:0000803) | 2.01829094 |
| 69 | Broad-based gait (HP:0002136) | 2.00985555 |
| 70 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.00959670 |
| 71 | Lethargy (HP:0001254) | 2.00102323 |
| 72 | Epidermoid cyst (HP:0200040) | 1.97504181 |
| 73 | Pancreatic cysts (HP:0001737) | 1.95842700 |
| 74 | Volvulus (HP:0002580) | 1.94365070 |
| 75 | Abnormality of the fovea (HP:0000493) | 1.92028071 |
| 76 | Abnormality of nucleobase metabolism (HP:0010932) | 1.85571010 |
| 77 | Hypolipoproteinemia (HP:0010981) | 1.84524953 |
| 78 | Generalized aminoaciduria (HP:0002909) | 1.83129207 |
| 79 | Neonatal hypoglycemia (HP:0001998) | 1.82844134 |
| 80 | Abnormality of vitamin metabolism (HP:0100508) | 1.82776928 |
| 81 | Abnormality of the renal cortex (HP:0011035) | 1.82067400 |
| 82 | Abnormality of the renal medulla (HP:0100957) | 1.82002097 |
| 83 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.81633506 |
| 84 | Optic disc pallor (HP:0000543) | 1.79728990 |
| 85 | Hyperammonemia (HP:0001987) | 1.79686317 |
| 86 | Neonatal respiratory distress (HP:0002643) | 1.79340988 |
| 87 | Progressive macrocephaly (HP:0004481) | 1.78007315 |
| 88 | Acute necrotizing encephalopathy (HP:0006965) | 1.77722862 |
| 89 | Pendular nystagmus (HP:0012043) | 1.77394469 |
| 90 | Methylmalonic aciduria (HP:0012120) | 1.77309477 |
| 91 | Pulmonary embolism (HP:0002204) | 1.76621428 |
| 92 | Hypoproteinemia (HP:0003075) | 1.76437275 |
| 93 | Metabolic acidosis (HP:0001942) | 1.74309495 |
| 94 | Ketosis (HP:0001946) | 1.73496534 |
| 95 | Increased serum pyruvate (HP:0003542) | 1.73349832 |
| 96 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.73080256 |
| 97 | Enlarged kidneys (HP:0000105) | 1.72649872 |
| 98 | Type II lissencephaly (HP:0007260) | 1.72247733 |
| 99 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.71998946 |
| 100 | Cerebellar dysplasia (HP:0007033) | 1.71851369 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.11292752 |
| 2 | ZAK | 3.39834503 |
| 3 | PINK1 | 3.08840961 |
| 4 | CASK | 3.06535875 |
| 5 | WNK3 | 2.63695971 |
| 6 | TXK | 2.44952614 |
| 7 | DYRK3 | 2.44482230 |
| 8 | NUAK1 | 2.34021401 |
| 9 | FGFR2 | 2.27908475 |
| 10 | WNK4 | 2.17369695 |
| 11 | TLK1 | 1.87052591 |
| 12 | TAF1 | 1.86862962 |
| 13 | MAP2K7 | 1.84337549 |
| 14 | NTRK3 | 1.84124728 |
| 15 | STK16 | 1.82923597 |
| 16 | EPHA3 | 1.79156085 |
| 17 | MUSK | 1.77775991 |
| 18 | PIK3CG | 1.75554669 |
| 19 | CAMKK2 | 1.72943564 |
| 20 | MARK1 | 1.69998443 |
| 21 | EIF2AK3 | 1.62961434 |
| 22 | MAP3K4 | 1.52932918 |
| 23 | MAPK13 | 1.52561509 |
| 24 | TAOK3 | 1.51366519 |
| 25 | ADRBK2 | 1.48593924 |
| 26 | BCR | 1.41014487 |
| 27 | BMPR1B | 1.39805110 |
| 28 | PAK3 | 1.39135289 |
| 29 | DYRK2 | 1.28574330 |
| 30 | MAP4K2 | 1.21679562 |
| 31 | BCKDK | 1.20134623 |
| 32 | VRK1 | 1.19933486 |
| 33 | PIK3CA | 1.18475597 |
| 34 | TIE1 | 1.02111611 |
| 35 | INSRR | 0.99638064 |
| 36 | PBK | 0.99260963 |
| 37 | IRAK1 | 0.94482689 |
| 38 | GRK6 | 0.93362549 |
| 39 | ICK | 0.91920159 |
| 40 | ACVR1B | 0.88264064 |
| 41 | CSNK1G2 | 0.88243204 |
| 42 | TRIM28 | 0.85721436 |
| 43 | BRSK2 | 0.82789039 |
| 44 | FES | 0.81158732 |
| 45 | TYRO3 | 0.81051132 |
| 46 | PRKCG | 0.80410265 |
| 47 | DYRK1A | 0.79895833 |
| 48 | EPHA4 | 0.79306522 |
| 49 | MAP3K12 | 0.79289533 |
| 50 | KIT | 0.78262805 |
| 51 | MAP2K4 | 0.77944513 |
| 52 | PRKCE | 0.77792845 |
| 53 | NLK | 0.77574328 |
| 54 | STK39 | 0.76072713 |
| 55 | PRKACA | 0.74480430 |
| 56 | STK38L | 0.70929090 |
| 57 | ITK | 0.70908895 |
| 58 | DAPK2 | 0.70041619 |
| 59 | MAP3K7 | 0.65956759 |
| 60 | PRKACG | 0.65124821 |
| 61 | GRK1 | 0.64909853 |
| 62 | SGK2 | 0.59867890 |
| 63 | RPS6KA6 | 0.59694849 |
| 64 | FGFR3 | 0.58293957 |
| 65 | ERBB3 | 0.58086608 |
| 66 | OXSR1 | 0.57903647 |
| 67 | PKN1 | 0.57143228 |
| 68 | STK11 | 0.55921807 |
| 69 | VRK2 | 0.54815820 |
| 70 | CSNK1G1 | 0.54752518 |
| 71 | STK3 | 0.53030057 |
| 72 | MAPK15 | 0.52899924 |
| 73 | AKT3 | 0.52500355 |
| 74 | PRKG1 | 0.51032926 |
| 75 | TEC | 0.50021499 |
| 76 | PRKACB | 0.49556791 |
| 77 | MARK3 | 0.49520239 |
| 78 | RPS6KA5 | 0.49038477 |
| 79 | OBSCN | 0.45822947 |
| 80 | CSNK1G3 | 0.44226583 |
| 81 | PRKCQ | 0.43618260 |
| 82 | RPS6KL1 | 0.43582490 |
| 83 | RPS6KC1 | 0.43582490 |
| 84 | SGK223 | 0.42931998 |
| 85 | SGK494 | 0.42931998 |
| 86 | CCNB1 | 0.42491685 |
| 87 | MAPK4 | 0.40750634 |
| 88 | CAMKK1 | 0.40393096 |
| 89 | PRKCA | 0.40089491 |
| 90 | CSNK1D | 0.40080393 |
| 91 | MAPK11 | 0.39897906 |
| 92 | BTK | 0.39877110 |
| 93 | TNIK | 0.39336293 |
| 94 | ABL2 | 0.39212329 |
| 95 | ERBB2 | 0.39147196 |
| 96 | MAP2K2 | 0.38209789 |
| 97 | IKBKE | 0.37572862 |
| 98 | CDK5 | 0.37385709 |
| 99 | PLK3 | 0.36469124 |
| 100 | PLK2 | 0.35661110 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.24600768 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.12507583 |
| 3 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.64456307 |
| 4 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.25157584 |
| 5 | Retinol metabolism_Homo sapiens_hsa00830 | 3.21155872 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.12382137 |
| 7 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 3.11434633 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.98385765 |
| 9 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.72178881 |
| 10 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.64921602 |
| 11 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.60414682 |
| 12 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.31567393 |
| 13 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.30338917 |
| 14 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.19045432 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.18434502 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.16052168 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.08292241 |
| 18 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.98157273 |
| 19 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.96985674 |
| 20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.92615519 |
| 21 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.92170023 |
| 22 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.84945789 |
| 23 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.84814740 |
| 24 | Bile secretion_Homo sapiens_hsa04976 | 1.66896164 |
| 25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.58412701 |
| 26 | Peroxisome_Homo sapiens_hsa04146 | 1.50903426 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.49566467 |
| 28 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.48148777 |
| 29 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.43066757 |
| 30 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.14757384 |
| 31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.13954357 |
| 32 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.10062954 |
| 33 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.07016521 |
| 34 | Sulfur relay system_Homo sapiens_hsa04122 | 1.05839017 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.05074588 |
| 36 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.95243020 |
| 37 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.95023044 |
| 38 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.94469203 |
| 39 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.92527286 |
| 40 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.89563520 |
| 41 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.89412402 |
| 42 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.86884390 |
| 43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.86106950 |
| 44 | Parkinsons disease_Homo sapiens_hsa05012 | 0.85433826 |
| 45 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.84475906 |
| 46 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.83604892 |
| 47 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.83465404 |
| 48 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.77910792 |
| 49 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.76952947 |
| 50 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.76254717 |
| 51 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.70562605 |
| 52 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.69515539 |
| 53 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.66507207 |
| 54 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.65453115 |
| 55 | Nicotine addiction_Homo sapiens_hsa05033 | 0.64374022 |
| 56 | ABC transporters_Homo sapiens_hsa02010 | 0.59962593 |
| 57 | Metabolic pathways_Homo sapiens_hsa01100 | 0.59306506 |
| 58 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.55511213 |
| 59 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.53422111 |
| 60 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.52777367 |
| 61 | Basal transcription factors_Homo sapiens_hsa03022 | 0.50661229 |
| 62 | Protein export_Homo sapiens_hsa03060 | 0.49297783 |
| 63 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.47758020 |
| 64 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.47219196 |
| 65 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.46985871 |
| 66 | Huntingtons disease_Homo sapiens_hsa05016 | 0.45564924 |
| 67 | Ribosome_Homo sapiens_hsa03010 | 0.45240006 |
| 68 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.44896439 |
| 69 | Carbon metabolism_Homo sapiens_hsa01200 | 0.44094761 |
| 70 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.42161999 |
| 71 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.41775278 |
| 72 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.39261719 |
| 73 | Phototransduction_Homo sapiens_hsa04744 | 0.38134423 |
| 74 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.37393287 |
| 75 | Alzheimers disease_Homo sapiens_hsa05010 | 0.35920239 |
| 76 | Olfactory transduction_Homo sapiens_hsa04740 | 0.35912606 |
| 77 | Homologous recombination_Homo sapiens_hsa03440 | 0.34293496 |
| 78 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.31364865 |
| 79 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.29063216 |
| 80 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.28946104 |
| 81 | Circadian rhythm_Homo sapiens_hsa04710 | 0.28270479 |
| 82 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.26899282 |
| 83 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.26790796 |
| 84 | Cocaine addiction_Homo sapiens_hsa05030 | 0.25064873 |
| 85 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.24640772 |
| 86 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.22053252 |
| 87 | Lysine degradation_Homo sapiens_hsa00310 | 0.21059848 |
| 88 | Prion diseases_Homo sapiens_hsa05020 | 0.20940066 |
| 89 | GABAergic synapse_Homo sapiens_hsa04727 | 0.20338548 |
| 90 | Proteasome_Homo sapiens_hsa03050 | 0.19738988 |
| 91 | RNA polymerase_Homo sapiens_hsa03020 | 0.18145464 |
| 92 | Mineral absorption_Homo sapiens_hsa04978 | 0.16794123 |
| 93 | Taste transduction_Homo sapiens_hsa04742 | 0.16547271 |
| 94 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.16339006 |
| 95 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.16024069 |
| 96 | Morphine addiction_Homo sapiens_hsa05032 | 0.15509008 |
| 97 | Insulin secretion_Homo sapiens_hsa04911 | 0.14790713 |
| 98 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.13628311 |
| 99 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.13428813 |
| 100 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.13389426 |

